Page last updated: 2024-09-03

1,4-dideoxy-1,4-iminoarabinitol and Alloxan Diabetes

1,4-dideoxy-1,4-iminoarabinitol has been researched along with Alloxan Diabetes in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andersen, JV; Mackay, P; McCormack, JG; Ynddal, L1

Other Studies

1 other study(ies) available for 1,4-dideoxy-1,4-iminoarabinitol and Alloxan Diabetes

ArticleYear
Pharmacokinetics and anti-hyperglycaemic efficacy of a novel inhibitor of glycogen phosphorylase, 1,4-dideoxy-1,4-imino-d- arabinitol, in glucagon-challenged rats and dogs and in diabetic ob/ob mice.
    Diabetes, obesity & metabolism, 2003, Volume: 5, Issue:6

    Topics: Administration, Oral; Animals; Arabinose; Blood Glucose; Diabetes Mellitus, Experimental; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Glucagon; Glycogen Phosphorylase; Half-Life; Hypoglycemic Agents; Imino Furanoses; Injections, Intravenous; Male; Mice; Mice, Obese; Rats; Rats, Sprague-Dawley; Sugar Alcohols

2003